Related Experiment Video
Updated: May 23, 2025

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Spatial mapping and geographic variation of inflammatory bowel disease in Canada: a population-based study
Shane W Goodwin1, Michael Haan2, Yuhong Yuan1,3
1Department of Medicine, Lawson Health Research Institute, London Health Science Centre, London, ON, Canada.
Background And Aims:
Inflammatory bowel disease (IBD) poses significant challenges to healthcare systems, with rising prevalence globally. To address challenges of health resource allocation and understand the geographic distribution of disease in Canada, we explored spatial mapping of IBD across Canada.
Methods:
Data from 2009 to 2018 Canadian Community Health Survey identified individuals with IBD. Crude and adjusted prevalence rates were calculated, and spatial dependencies were analyzed using Moran's I. Local indicators of spatial association identified hot-spots where the prevalence of IBD was significantly different than neighboring areas. Spatial autoregressive models assessed the influence of sociodemographic factors on spatial dependencies.
Results:
Across 109 health regions, 492 560 individuals were included, representing 29 846 350 Canadians. Crohn's disease and ulcerative colitis were reported in 0.38% and 0.47% of Canadians, respectively. Age and sex-standardized prevalence ranged from 742 to 1267 per 100 000. Significant dependencies among health regions were found, but dependencies were explained by the distribution of sociodemographic characteristics in a region.
Conclusions:
Results demonstrated significant geographic variations in the prevalence of IBD in Canada. Evidence suggests that differences in prevalence between regions are primarily driven by individual demographics rather than geographical characteristics.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

